Published in Curr Med Res Opin on April 01, 2010
Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial. Arthritis Res Ther (2014) 0.84
A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience. Arch Med Sci (2013) 0.81
Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial. Clin Rheumatol (2015) 0.75
Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia. Drug Healthc Patient Saf (2016) 0.75
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32
Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch Ophthalmol (2007) 1.94
The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine (Phila Pa 1976) (2012) 1.92
Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol (2009) 1.88
How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain (2010) 1.80
Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. Value Health (2013) 1.77
Gender balance in the veterinary profession. Vet Rec (2011) 1.66
Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists. Appl Health Econ Health Policy (2014) 1.51
Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract (2006) 1.27
Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC Fam Pract (2010) 1.21
Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study. Pharmacoeconomics (2008) 1.20
The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes (2011) 1.19
Burden of illness of neovascular age-related macular degeneration in Canada. Can J Ophthalmol (2007) 1.18
A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing (2006) 1.14
Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med (2009) 1.11
Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res (2012) 1.06
The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis. Curr Med Res Opin (2009) 1.06
The current and future burden and cost of overactive bladder in five European countries. Eur Urol (2006) 1.06
Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study. Appl Health Econ Health Policy (2011) 1.05
Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. J Pain Res (2013) 1.03
Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press (2002) 1.03
Emotional expression, self-silencing, and distress tolerance in anorexia nervosa and chronic fatigue syndrome. Br J Clin Psychol (2011) 1.02
Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res (2013) 1.01
The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Manag Care Pharm (2012) 1.01
The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine. Vaccine (2003) 1.01
Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis. J Med Econ (2011) 0.99
Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the national health and wellness survey. Health Qual Life Outcomes (2012) 0.99
Assessing dimensionality and responsiveness of outcomes measures for patients with low back pain. Pain Pract (2011) 0.98
Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy. Diabetes Metab Syndr Obes (2011) 0.97
Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis. Patient Prefer Adherence (2013) 0.95
Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Curr Med Res Opin (2009) 0.94
Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis. BMC Musculoskelet Disord (2010) 0.94
Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care. J Med Econ (2011) 0.93
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care (2010) 0.92
Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey. BMC Musculoskelet Disord (2011) 0.92
Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales. Health Qual Life Outcomes (2009) 0.92
Evidence-based clinical guidelines: a new system to better determine true strength of recommendation. J Eval Clin Pract (2006) 0.91
Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum (2011) 0.91
Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract (2013) 0.91
A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. Clin Ther (2007) 0.91
Burden of illness associated with peripheral and central neuropathic pain among adults seeking treatment in the United States: a patient-centered evaluation. Pain Med (2014) 0.91
Treatment patterns among physician specialties in the management of fibromyalgia: results of a cross-sectional study in the United States. Curr Med Res Opin (2011) 0.91
Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK. J Med Econ (2011) 0.89
Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD. Respir Med (2011) 0.89
The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome. Sleep Med (2009) 0.88
Burden of illness of bilateral neovascular age-related macular degeneration in Spain. Curr Med Res Opin (2008) 0.88
Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin (2008) 0.88
Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. Pain Pract (2008) 0.88
ER:YAG laser for 3-dimensional debridement of canal systems: use of photon-induced photoacoustic streaming. Dent Today (2012) 0.87
Reduction in opioid-related adverse events and improvement in function with parecoxib followed by valdecoxib treatment after non-cardiac surgery: a randomized, double-blind, placebo-controlled, parallel-group trial. Clin Drug Investig (2009) 0.87
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis Rheum (2007) 0.87
Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties. Acta Ophthalmol (2008) 0.87
Use and costs of prescription medications and alternative treatments in patients with osteoarthritis and chronic low back pain in community-based settings. Pain Pract (2012) 0.87
Clinical characteristics, pharmacotherapy and healthcare resource use among patients with fibromyalgia newly prescribed gabapentin or pregabalin. Pain Pract (2009) 0.86
Identifying fibromyalgia-associated symptoms and conditions from a clinical perspective: a step toward evaluating healthcare resource utilization in fibromyalgia. Pain Pract (2010) 0.86
Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with fibromyalgia newly prescribed pregabalin or tricyclic antidepressants. J Med Econ (2011) 0.84
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurol (2012) 0.84
Pain responder analysis: use of area under the curve to enhance interpretation of clinical trial results. Pain Pract (2009) 0.83
Clinical and economic characteristics of patients with painful neuropathic disorders in Germany. Pain Pract (2008) 0.82
Direct and indirect economic costs among private-sector employees with osteoarthritis. J Occup Environ Med (2011) 0.82
Mortality associated with gastrointestinal bleeding events: Comparing short-term clinical outcomes of patients hospitalized for upper GI bleeding and acute myocardial infarction in a US managed care setting. Clin Exp Gastroenterol (2009) 0.82
Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications. Int J Technol Assess Health Care (2004) 0.82
The 'Healthy Dads, Healthy Kids' community effectiveness trial: study protocol of a community-based healthy lifestyle program for fathers and their children. BMC Public Health (2011) 0.81
Toward characterization and definition of fibromyalgia severity. BMC Musculoskelet Disord (2010) 0.81
Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin. Pain Pract (2011) 0.81
Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains. BMC Musculoskelet Disord (2012) 0.81
Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale. Ther Adv Musculoskelet Dis (2011) 0.81
Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin. Pain Med (2011) 0.81
Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US. J Med Econ (2012) 0.81
Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis. Clin Ther (2011) 0.81
The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective. J Med Econ (2012) 0.81
Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia. Am J Manag Care (2010) 0.80
Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: a study using the U.K. and Germany Mediplus databases. Pain Pract (2008) 0.80
Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States. J Med Econ (2012) 0.79
Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury. J Pain Res (2013) 0.79
Relationship between patient-reported disease severity and other clinical outcomes in osteoarthritis: a European perspective. J Med Econ (2011) 0.79
Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study. BMC Ophthalmol (2010) 0.78
Relationships between changes in pain severity and other patient-reported outcomes: an analysis in patients with posttraumatic peripheral neuropathic pain. Health Qual Life Outcomes (2011) 0.78
Retrospective evaluation of clinical characteristics, pharmacotherapy and healthcare resource use among patients prescribed pregabalin or duloxetine for diabetic peripheral neuropathy in usual care. Pain Pract (2010) 0.78
Further qualification of a therapeutic responder index for patients with chronic low back pain. J Rheumatol (2010) 0.77
Total serum bilirubin as a negative prognostic factor in idiopathic canine chronic hepatitis. J Vet Diagn Invest (2014) 0.77
Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K. Pain Pract (2008) 0.77
Functional Impairment Is a Risk Factor for Knee Replacement in the Multicenter Osteoarthritis Study. Clin Orthop Relat Res (2015) 0.77
Costs, work absence, and adherence in patients with partial onset seizures prescribed gabapentin or pregabalin. Epilepsy Res (2012) 0.76
Applying area-under-the-curve analysis to enhance interpretation of response profiles: an application to sleep quality scores in patients with fibromyalgia. Qual Life Res (2010) 0.76
An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study. Curr Med Res Opin (2004) 0.76
Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective. J Med Econ (2009) 0.76
Electroglottographic analysis of actresses and nonactresses' voices in different levels of intensity. J Voice (2013) 0.76
Use of human spironolactone in dogs with heart failure. Vet Rec (2008) 0.75
Are GP leaders scared of sex? Br J Gen Pract (2002) 0.75